4d Molecular Therapeutics In shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $198k | 15k | 13.30 |
| 2024-12-31 | $364k | 65k | 5.57 |
| 2024-09-30 | $295k | 27k | 10.81 |
| 2023-06-30 | $394k | 22k | 18.07 |
| 2023-03-31 | $839k | 49k | 17.19 |
| 2022-12-31 | $1.1M | 48k | 22.21 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management